$LGND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.32 | 2,700 | 30,564 | 10,772 | 13.5 K to 10.8 K (-20.04 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.31 | 4,464 | 50,488 | 13,472 | 17.9 K to 13.5 K (-24.89 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.35 | 459 | 5,210 | 17,936 | 18.4 K to 17.9 K (-2.50 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.40 | 1,918 | 21,865 | 18,395 | 20.3 K to 18.4 K (-9.44 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Buy | M | 9.25 | 16,667 | 154,170 | 20,313 | 3.6 K to 20.3 K (+457.13 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.40 | 5,208 | 59,371 | 3,646 | 8.9 K to 3.6 K (-58.82 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Buy | M | 9.25 | 5,208 | 48,174 | 8,854 | 3.6 K to 8.9 K (+142.84 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.35 | 1,191 | 13,518 | 3,646 | 4.8 K to 3.6 K (-24.62 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Buy | M | 7.25 | 1,191 | 8,635 | 4,837 | 3.6 K to 4.8 K (+32.67 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Sell | S | 11.35 | 5,476 | 62,153 | 3,646 | 9.1 K to 3.6 K (-60.03 %) |
Nov 21 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Buy | M | 7.25 | 5,476 | 39,701 | 9,122 | 3.6 K to 9.1 K (+150.19 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 100 | 931 | 26,914 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 6,021 | 56,071 | 27,014 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 2,800 | 26,075 | 33,035 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 4,400 | 40,975 | 35,835 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 1,600 | 14,900 | 40,235 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 4,551 | 42,381 | 41,835 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 1,200 | 11,175 | 46,386 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 195 | 1,816 | 47,586 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 3,895 | 36,272 | 47,781 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 2,438 | 22,704 | 51,676 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 100 | 931 | 54,114 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 600 | 5,588 | 54,214 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 3,800 | 35,388 | 54,814 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 300 | 2,794 | 58,614 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 500 | 4,656 | 58,914 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 200 | 1,863 | 59,414 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 5,800 | 54,013 | 59,614 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 1,100 | 10,244 | 65,414 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.31 | 400 | 3,725 | 66,514 | |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.44 | 3,300 | 37,752 | 0 | 3.3 K to 0 (-100.00 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.43 | 700 | 8,001 | 3,300 | 4 K to 3.3 K (-17.50 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.42 | 100 | 1,142 | 4,000 | 4.1 K to 4 K (-2.44 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.41 | 400 | 4,564 | 4,100 | 4.5 K to 4.1 K (-8.89 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.40 | 3,427 | 39,068 | 4,500 | 7.9 K to 4.5 K (-43.23 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.38 | 100 | 1,138 | 7,927 | 8 K to 7.9 K (-1.25 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.35 | 568 | 6,447 | 8,027 | 8.6 K to 8 K (-6.61 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.48 | 100 | 1,148 | 84,951 | 85.1 K to 85 K (-0.12 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 100 | 931 | 85,051 | 85 K to 85.1 K (+0.12 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.25 | 6,021 | 67,736 | 84,951 | 91 K to 85 K (-6.62 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 6,021 | 56,071 | 90,972 | 85 K to 91 K (+7.09 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.26 | 2,800 | 31,528 | 84,951 | 87.8 K to 85 K (-3.19 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 2,800 | 26,075 | 87,751 | 85 K to 87.8 K (+3.30 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.27 | 4,400 | 49,588 | 84,951 | 89.4 K to 85 K (-4.92 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 4,400 | 40,975 | 89,351 | 85 K to 89.4 K (+5.18 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.28 | 1,600 | 18,048 | 84,951 | 86.6 K to 85 K (-1.85 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 1,600 | 14,900 | 86,551 | 85 K to 86.6 K (+1.88 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.30 | 4,551 | 51,426 | 84,951 | 89.5 K to 85 K (-5.08 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 4,551 | 42,381 | 89,502 | 85 K to 89.5 K (+5.36 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.31 | 1,200 | 13,572 | 84,951 | 86.2 K to 85 K (-1.39 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 1,200 | 11,175 | 86,151 | 85 K to 86.2 K (+1.41 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.34 | 195 | 2,211 | 84,951 | 85.1 K to 85 K (-0.23 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 195 | 1,816 | 85,146 | 85 K to 85.1 K (+0.23 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.35 | 3,895 | 44,208 | 84,951 | 88.8 K to 85 K (-4.38 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 3,895 | 36,272 | 88,846 | 85 K to 88.8 K (+4.58 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.36 | 2,438 | 27,696 | 84,951 | 87.4 K to 85 K (-2.79 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 2,438 | 22,704 | 87,389 | 85 K to 87.4 K (+2.87 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.37 | 100 | 1,137 | 84,951 | 85.1 K to 85 K (-0.12 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 100 | 931 | 85,051 | 85 K to 85.1 K (+0.12 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.38 | 600 | 6,828 | 84,951 | 85.6 K to 85 K (-0.70 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 600 | 5,588 | 85,551 | 85 K to 85.6 K (+0.71 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.39 | 3,800 | 43,282 | 84,951 | 88.8 K to 85 K (-4.28 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 3,800 | 35,388 | 88,751 | 85 K to 88.8 K (+4.47 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.40 | 300 | 3,420 | 84,951 | 85.3 K to 85 K (-0.35 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 300 | 2,794 | 85,251 | 85 K to 85.3 K (+0.35 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.41 | 500 | 5,705 | 84,951 | 85.5 K to 85 K (-0.59 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 500 | 4,656 | 85,451 | 85 K to 85.5 K (+0.59 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.42 | 200 | 2,284 | 84,951 | 85.2 K to 85 K (-0.23 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 200 | 1,863 | 85,151 | 85 K to 85.2 K (+0.24 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.44 | 5,800 | 66,352 | 84,951 | 90.8 K to 85 K (-6.39 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 5,800 | 54,013 | 90,751 | 85 K to 90.8 K (+6.83 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.45 | 1,100 | 12,595 | 84,951 | 86.1 K to 85 K (-1.28 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 1,100 | 10,244 | 86,051 | 85 K to 86.1 K (+1.29 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.46 | 400 | 4,584 | 84,951 | 85.4 K to 85 K (-0.47 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.31 | 400 | 3,725 | 85,351 | 85 K to 85.4 K (+0.47 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.37 | 1,600 | 18,192 | 84,951 | 86.6 K to 85 K (-1.85 %) |
Nov 20 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 11.35 | 4,577 | 51,949 | 86,551 | 91.1 K to 86.6 K (-5.02 %) |
Sep 29 2006 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 10.10 | 20,000 | 202,000 | 20,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | ROCCA MICHAEL A | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | PECK CARL C | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | President, CEO & Ch ... | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Sep 28 2006 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
Aug 04 2006 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 | |
Aug 04 2006 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | A | 9.20 | 150,000 | 1,380,000 | 150,000 | |
Jun 16 2006 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 3.30 | 3,409 | 11,250 | 3,409 | |
Jun 16 2006 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Option Exercise | A | 3.30 | 3,409 | 11,250 | 3,409 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Option Exercise | A | 11.90 | 50,000 | 595,000 | 50,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | PETTTIT WILLIAM A | Sr. V-P, HR and Adm ... | Option Exercise | A | 11.90 | 20,000 | 238,000 | 20,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | NEGRO-VILAR ANDRES | Exe V-P, R & D, CSO | Option Exercise | A | 11.90 | 25,000 | 297,500 | 25,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | MERTES TOD | V-P, Controller & T ... | Option Exercise | A | 11.90 | 20,000 | 238,000 | 20,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Option Exercise | A | 11.90 | 25,000 | 297,500 | 25,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | A | 11.90 | 20,000 | 238,000 | 20,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | LITALIEN JAMES J | Sr. V-P, Reg Affair ... | Option Exercise | A | 11.90 | 20,000 | 238,000 | 20,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Option Exercise | A | 11.90 | 15,000 | 178,500 | 15,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | CROUCH TAYLOR | Sr. V-P, Ops & Pres ... | Option Exercise | A | 11.90 | 20,000 | 238,000 | 20,000 | |
Mar 14 2006 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Option Exercise | A | 11.90 | 25,000 | 297,500 | 25,000 | |
Mar 02 2006 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Option Exercise | M | 3.73 | 1,841 | 6,872 | 0 | |
Mar 02 2006 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Buy | M | 3.73 | 1,841 | 6,872 | 26,335 | 24.5 K to 26.3 K (+7.52 %) |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | ROCCA MICHAEL A | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | PECK CARL C | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Feb 01 2006 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | A | 12.40 | 10,000 | 124,000 | 10,000 | |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | PECK CARL C | Director | Grant | A | 0.00 | 2,378 | 0 | 8,378 | 6 K to 8.4 K (+39.63 %) |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,378 | 0 | 7,378 | 5 K to 7.4 K (+47.56 %) |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | ROCCA MICHAEL A | Director | Grant | A | 0.00 | 3,676 | 0 | 11,676 | 8 K to 11.7 K (+45.95 %) |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | Perry Jeffrey R | Director | Grant | A | 11.56 | 2,378 | 27,490 | 2,378 | 0 to 2.4 K |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | Roberts Brigette | Director | Grant | A | 11.56 | 2,378 | 27,490 | 2,378 | 0 to 2.4 K |
Jan 06 2006 | LGND | LIGAND PHARMACEUTI ... | Loeb Daniel S | Director | Grant | A | 11.56 | 2,378 | 27,490 | 7,377,378 | 7.4 M to 7.4 M (+0.03 %) |
Dec 12 2005 | LGND | LIGAND PHARMACEUTI ... | Roberts Brigette | Director | Option Exercise | A | 11.35 | 20,000 | 227,000 | 20,000 | |
Dec 12 2005 | LGND | LIGAND PHARMACEUTI ... | Perry Jeffrey R | Director | Option Exercise | A | 11.35 | 20,000 | 227,000 | 20,000 | |
Dec 12 2005 | LGND | LIGAND PHARMACEUTI ... | Loeb Daniel S | Director | Option Exercise | A | 11.35 | 20,000 | 227,000 | 20,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Option Exercise | A | 7.25 | 100,000 | 725,000 | 100,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | PETTTIT WILLIAM A | Sr. V-P, HR and Adm ... | Option Exercise | A | 7.25 | 10,000 | 72,500 | 10,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | NEGRO-VILAR ANDRES | Exe V-P, R & D, CSO | Option Exercise | A | 7.25 | 35,000 | 253,750 | 35,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | MERTES TOD | V-P, Controller & T ... | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | A | 7.25 | 35,000 | 253,750 | 35,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | LITALIEN JAMES J | Sr. V-P, Reg Affair ... | Option Exercise | A | 7.25 | 10,000 | 72,500 | 10,000 | |
Jul 07 2005 | LGND | LIGAND PHARMACEUTI ... | BROADDUS WARNER R | V-P, Gen. Counsel & ... | Option Exercise | A | 7.25 | 20,000 | 145,000 | 20,000 | |
May 17 2005 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Option Exercise | M | 5.81 | 16,237 | 94,378 | 0 | |
May 17 2005 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Buy | M | 5.81 | 16,237 | 94,378 | 16,237 | 0 to 16.2 K |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | PECK CARL C | Director | Option Exercise | A | 3.73 | 1,841 | 6,872 | 1,841 | |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 3.73 | 3,683 | 13,749 | 3,683 | |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 3.73 | 1,841 | 6,872 | 1,841 | |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | GROOM JOHN | Director | Option Exercise | A | 3.73 | 3,683 | 13,749 | 3,683 | |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Option Exercise | A | 3.73 | 1,841 | 6,872 | 1,841 | |
Jan 05 2005 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | A | 3.73 | 2,009 | 7,500 | 2,009 | |
Nov 12 2004 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Buy | P | 8.82 | 500 | 4,410 | 500 | 0 to 500 |
Aug 19 2004 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Option Exercise | M | 5.50 | 18,082 | 99,451 | 0 | |
Aug 19 2004 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Buy | M | 5.50 | 18,082 | 99,451 | 411,725 | 393.6 K to 411.7 K (+4.59 %) |
Sep 08 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.10 | 24,607 | 223,924 | 0 | |
Sep 08 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 8.65 | 11,638 | 100,629 | 0 | |
Sep 08 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.10 | 24,607 | 223,924 | 89,310 | 64.7 K to 89.3 K (+38.03 %) |
Sep 08 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 8.65 | 11,638 | 100,629 | 64,703 | 53.1 K to 64.7 K (+21.93 %) |
Aug 06 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 5.50 | 5,700 | 31,350 | 0 | |
Aug 06 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 5.50 | 5,700 | 31,350 | 53,065 | 47.4 K to 53.1 K (+12.03 %) |
Jul 09 2004 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Option Exercise | A | 14.39 | 143,051 | 2,058,504 | 150,000 | |
Jul 09 2004 | LGND | LIGAND PHARMACEUTI ... | ROBINSON DAVID E | Pres, CEO & Chairma ... | Option Exercise | A | 14.39 | 6,949 | 99,996 | 6,949 | |
Jul 06 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 17.05 | 2,500 | 42,625 | 47,365 | 49.9 K to 47.4 K (-5.01 %) |
Jul 06 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 17.00 | 1,500 | 25,500 | 49,865 | 51.4 K to 49.9 K (-2.92 %) |
Jun 22 2004 | LGND | LIGAND PHARMACEUTI ... | ROCCA MICHAEL A | Director | Option Exercise | A | 17.16 | 10,000 | 171,600 | 10,000 | |
Jun 22 2004 | LGND | LIGAND PHARMACEUTI ... | PECK CARL C | Director | Option Exercise | A | 17.16 | 10,000 | 171,600 | 10,000 | |
Jun 22 2004 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 17.16 | 10,000 | 171,600 | 10,000 | |
Jun 22 2004 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 17.16 | 10,000 | 171,600 | 10,000 |